Related Organization(s)

You just read:

Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug

News provided by

GC Pharma

Apr 03, 2019, 23:11 ET